Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,654
Total Claims
$1.0M
Drug Cost
599
Beneficiaries
$1,696
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-75%
Opioid rate vs peers
0.6% vs 2.2% avg
+20%
Cost per patient vs peers
$1,696 vs $1,411 avg
+34%
Brand preference vs peers
14.2% vs 10.6% avg
Opioid Prescribing
0.6%
Opioid Rate
48
Opioid Claims
$179
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,223 claims · $851K
Generic: 7,361 claims · $162K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 112 | $113K |
| Semaglutide | 84 | $99K |
| Dulaglutide | 55 | $78K |
| Empagliflozin | 62 | $77K |
| Rivaroxaban | 46 | $50K |
| Tirzepatide | 38 | $44K |
| Insulin Degludec | 32 | $39K |
| Dapagliflozin Propanediol | 38 | $38K |
| Fluticasone/Umeclidin/Vilanter | 17 | $32K |
| Rosuvastatin Calcium | 691 | $23K |
| Insulin Glargine,hum.Rec.Anlog | 32 | $21K |
| Sitagliptin Phosphate | 23 | $21K |
| Budesonide/Formoterol Fumarate | 31 | $20K |
| Fluticasone/Vilanterol | 39 | $19K |
| Semaglutide | 12 | $17K |
Prescribing Profile
Patient Profile
75
Avg Age
48%
Female
1.11
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data